Shortage of Technetium TC-99M Pyrophosphate Kit Injection
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Technetium TC-99M Pyrophosphate Kit Injection is currently in shortage, affecting its availability as an injection for medical imaging purposes.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Technetium TC-99M Pyrophosphate Kit Injection.
What's in Shortage
The generic drug Technetium TC-99M Pyrophosphate Kit Injection, also known by the brand name TECHNESCAN PYP, is currently in shortage. It is available as an injection and falls under the therapeutic category of medical imaging. The shortage was first posted on 12/27/2023 and last updated on 04/02/2026.
Which Manufacturers Are Affected
Curium US LLC is the affected manufacturer, with limited availability. They are on allocation through Q2 2026. The presentation is Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20). For further details, patients can contact them at 888-744-1414.
Why There's a Shortage
The shortage is due to a shortage of an active ingredient.
What Patients Should Do
Patients who depend on this medication should talk to their pharmacist or healthcare provider about the current status and possible options. They may also contact the manufacturer directly for more information. Please remember that patients should always consult their healthcare provider and not make any changes without professional guidance.
Source
This information is sourced from the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,172 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.